Latest Insider Transactions at Neurocrine Biosciences Inc (NBIX)
This section provides a real-time view of insider transactions for Neurocrine Biosciences Inc (NBIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROCRINE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROCRINE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2021
|
Haig P. Bozigian Chief Development Officer |
SELL
Open market or private sale
|
Direct |
704
-0.46%
|
$79,552
$113.79 P/Share
|
|
Feb 05
2021
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,677
-1.32%
|
$302,501
$113.93 P/Share
|
|
Jan 26
2021
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-1.25%
|
$48,000
$120.0 P/Share
|
|
Jan 26
2021
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+1.83%
|
$12,300
$41.78 P/Share
|
|
Jan 26
2021
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
1,100
-1.86%
|
$130,900
$119.97 P/Share
|
|
Jan 26
2021
|
Malcolm Lloyd Smith Chief Integration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+1.83%
|
$38,500
$35.99 P/Share
|
|
Jan 26
2021
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
400
-0.18%
|
$48,000
$120.0 P/Share
|
|
Jan 25
2021
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,077
-12.92%
|
$609,240
$120.03 P/Share
|
|
Jan 25
2021
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,477
+14.27%
|
$142,557
$41.78 P/Share
|
|
Jan 25
2021
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
17,570
-16.48%
|
$2,090,830
$119.97 P/Share
|
|
Jan 25
2021
|
Malcolm Lloyd Smith Chief Integration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,570
+13.99%
|
$597,380
$34.99 P/Share
|
|
Jan 25
2021
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
1,600
-0.71%
|
$192,000
$120.03 P/Share
|
|
Jan 08
2021
|
Kevin Charles Gorman Director |
SELL
Open market or private sale
|
Direct |
308,250
-25.87%
|
$33,907,500
$110.22 P/Share
|
|
Jan 08
2021
|
Kevin Charles Gorman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
308,250
+20.54%
|
$2,466,000
$8.66 P/Share
|
|
Jan 08
2021
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,632
-14.24%
|
$292,152
$111.06 P/Share
|
|
Dec 03
2020
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,806
-9.4%
|
-
|
|
Dec 01
2020
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,645
-12.52%
|
$154,630
$94.66 P/Share
|
|
Nov 12
2020
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,257
-18.39%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Haig P. Bozigian Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,257
-1.46%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,257
-16.31%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,257
-2.25%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Kevin Charles Gorman Director |
SELL
Open market or private sale
|
Direct |
3,390
-0.76%
|
$305,100
$90.78 P/Share
|
|
Nov 12
2020
|
Dimitri E. Grigoriadis Chief Research Officer |
SELL
Open market or private sale
|
Direct |
2,257
-2.69%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,257
-6.98%
|
$203,130
$90.72 P/Share
|
|
Nov 12
2020
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
2,257
-7.22%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,257
-14.34%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,257
-11.48%
|
$203,130
$90.71 P/Share
|
|
Nov 02
2020
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,595
-57.26%
|
$1,977,120
$96.53 P/Share
|
|
Nov 02
2020
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,595
+36.41%
|
$720,825
$35.99 P/Share
|
|
Oct 02
2020
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
987
-9.37%
|
$93,765
$95.26 P/Share
|